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Background: Diabetes in cystic ﬁbrosis (CF) is a result of exocrine pancreas alteration followed by endocrine dysfunction at a later stage.
Microparticles (MPs) are plasma membrane fragments shed from stimulated or damaged cells that act as cellular effectors. Our aim was to identify
a new form of interaction between exocrine and endocrine pancreatic cells mediated by exocrine MPs, in the context of recurrent infection in CF.
Methods: MPs from either human exocrine CFTRΔF508-mutated (CFPAC-1) cells or exocrine normal pancreatic (PANC-1) cells were collected
after treatment by LPS from Pseudomonas aeruginosa and applied to rat endocrine normal insulin-secreting RIN-m5F cells. MP membrane
integration in target cells was established by confocal microscopy and ﬂow cytometry using PKH26 lipid probe. Apoptosis, lysosomal activity,
insulin secretion were measured after 18 h. MP-mediated NF-κB activation was measured in HEK-Blue reporter cells by SEAP reporter gene
system and in RIN-m5F cells by Western blot. In endocrine normal cells, CFTR inhibition was achieved using Inhibitor-172.
Results: Compared to PANC-1, MPs from CFPAC-1 signiﬁcantly reduced insulin secretion and lysosomal activity in RIN-m5F. MPs induced NF-
κB activation by increasing the level of IκB phosphorylation. Moreover, the inhibition of NF-κB activation using speciﬁc inhibitors was associated
with a restored insulin secretion. Interestingly, CFTR inhibition in normal RIN-m5F cells promoted apoptosis and decreased insulin secretion.
Conclusions: During recurrent infections associated with CF, exocrine MPs may contribute to endocrine cell dysfunction via NF-κB pathways.
Membrane CFTR dysfunction is associated with decreased insulin secretion.
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One of the most important complication in cystic fibrosis (CF)
patients is the bacterial colonization of airways favored by the
over-consistent mucosa. Infection by Staphylococcus aureus
occurs at early age and approximately 70% of CF patients areby Elsevier B.V. All rights reserved.
220 A.A. Constantinescu et al. / Journal of Cystic Fibrosis 13 (2014) 219–226infected by Pseudomonas aeruginosa (P. aeruginosa) after the
age of 20. In most of cases, infection becomes recurrent, leading
to progressive lung destruction and respiratory failure [1].
Due to constant improvement in therapy, life expectancy in
CF sufferers has increased dramatically. However, patients now
live long enough to develop one morbid consequence of CF:
CF-related diabetes (CFRD) that has been associated with a
nearly 6-fold greater mortality rate [2]. This specific form of
diabetes is characterized by impaired first-phase insulin and
C-peptide secretion, in association with pancreatic insufficiency
as a consequence of the exocrine fibrosis. Exocrine pancreatic
insufficiency affects about 85% to 90% of CF patients [3]. CFRD
prevalence reaches almost 50% of adults over 40 years [4].
Multiple pancreatic dysfunctions like islet destruction linked to
exocrine condition, insulin resistance, decreased secretion of
glucagon-like peptide (GLP-1) and inefficient gastric inhibitory
peptide (GIP) have been reported in CF [2].
CFTRΔF508 is the most common mutation in CF patients
with typical retention of CFTR protein in the Endoplasmic
Reticulum [5]. CFTR is a cyclic AMP-regulated ion channel
responsible for the chloride ion transport across epithelial cell
surface. Other functions of CFTR in the metabolism balance [6]
or in the defense against P. aeruginosa endotoxin [7] have also
been described. CFTR dysfunction mainly leads to excessive
viscosity of epithelial secretions, causing the obstruction and
damage in many organs, including the exocrine pancreas [3]. In
a previous work from the laboratory, CFTRΔF508 mutation
was associated with exaggerated apoptosis [8].
Microparticles (MPs) are submicronic plasma membrane
fragments released from stressed cells that carry membrane and
bioactive proteins from the parental cell. MPs behave as true
intercellular shuttles disseminating signals to neighboring or
distant target cells. Mechanisms of such interactions are not
fully deciphered. In clinical issues, elevated plasma concentra-
tion of MPs is associated with thrombotic disorders, inflam-
mation, or degenerative diseases [9,10]. Recently, MPs from
the sputum of CF patients were found deleterious when injected
in mice [11].
Because apoptosis is associated with plasma membrane
remodeling and shedding of MPs [8], we questioned their role
in the cross-talk between exocrine and endocrine cells. The aim
of the present work was to decipher the incidence of CFTR
deficiency on insulin secreted by endocrine cells and, if so, to
determine how MPs mediate interactions between exocrine and
endocrine pancreas in the context of CF recurrent infections
with P. aeruginosa.
2. Materials and methods
2.1. Cell lines
Human pancreatic exocrine cell lines PANC-1 (CRL-1469™)
and CFPAC-1 (CRL-1918™) presenting the CFTRΔF508
mutation were purchased from ATCC (Manassas, USA) and
grown as recommended by manufacturer in DMEM and IMDM
respectively, with 4.5% glucose, 1% penicillin and 1% streptomy-
cin. Rat insulin-secreting β-cell line RIN-m5F (CRL-11605™)was grown in RPMI 1640 containing 4.5% glucose, 10 mM
HEPES, 2 mM glutamine, 1 mM sodium pyruvate and 0.2%
gentamicin. Cell media were purchased from PAN™ Biotech
GmbH (Aidenbach, Germany).
Secreted embryonic alkaline phosphatase (SEAP) reporter cell
lines HEK-Blue™were grown as recommended by manufacturer
(InvivoGen, San Diego, USA) in DMEM, 0.5% penicillin, 0.2%
Normocin™. HEK-hTLR4 initiate Nuclear Factor-kappaB
(NF-κB) pathway in response to LPS binding to TLR4, while
HEK-Null2 lack TLR4 receptor. After at least three passages,
selection antibiotics were applied: 100 μg/mL Zeocin™ for
HEK-Null2 cells and 4 μL/mL of 250-fold concentrated
HEK-Blue™ Selection stock solution for control HEK-hTLR4.
All cells were grown in 10% FBS-supplemented media and
incubated in 5% CO2 atmosphere at 37 °C.
2.2. Inhibitors and pharmacological agents
In non-mutated cells, the inhibition of CFTR activity at
membrane surface was achieved after 18 h (RIN-m5F) or 24 h
(PANC-1) treatment by 5–25 μM Inhibitor-172 (Inh-172).
Inhibition of NF-κB pathways was achieved using 10 μM
Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor (IRAKi),
or 10 μM (5Z)-7-Oxozeaenol, Curvularia sp. (TAK-1i), a potent
ATP-competitive irreversible inhibitor of ERK2, TAK-1 (MKK7)
and MEK1. All inhibitors were purchased from Calbiochem®
(Billerica, USA). Lipopolysaccharide (LPS) from P. aeruginosa
(serotype 1022, ATCC 27316 strain) was purchased from Sigma
(St. Louis, USA).
2.3. Microparticle production
MPs were produced in vitro and collected from 1 μg/mL
LPS-treated exocrine cells after 24 h. In some experiments, MPs
from PANC-1 cells treated by additional 5 μM CFTRi were
collected. MPs were isolated from cell conditioned medium by
sequential centrifugation steps under sterile conditions. Cells and
debris were first discarded by a 2-step 800 g centrifugation, and
supernatant further submitted to 13,000 g, at 4 °C for 60 min.
The final suspension was kept less than 30 days at 4 °C. MP
measurement was performed by prothrombinase assay after
capture onto annexin-5 as previously described [12]. The assay
allows extensive washing of insolubilized MPs, taking advantage
of the high affinity of annexin-5 for phosphatidylserine (PhtdSer)
exposed by MP surface. MP concentration is determined as
PhtdSer equivalent, using the MP ability to catalyze the assembly
of the prothrombinase complex.
2.4. Cellular stress and MP-mediated cross-talk
Endocrine RIN-m5F cells were treated by 10 nM exocrine
MPs alone or in combination with 1 μg/mL LPS during 18 h.
2.5. Probing of exocrine MP transfer to target endocrine cells
Microparticle fluorescent staining was achieved by addition
of 2 μM of PKH26 lipid probe (Sigma) per 30–60 picomoles
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(13,000 g, 60 min.). Interaction of PKH26-labeled MPs and target
endocrine cells was probed by flow cytometry using a FACS-scan
cytometer (Becton Dickinson) and by confocal microscopy
(Leica FW4000 platform, Leica Microsystems GmbH) after 18 h
treatment.
2.6. Cellular measurements
Apoptosis was measured in ethanol-permeabilized cells by
hypodiploid DNAprobing using 100 μg/mL propidium iodide and
flow cytometry. Lysosomal activity was measured in 96-well
plates by Neutral Red (Generi Biotech; Hradec Kralove, Czech
Republic) assay which is based on the absorption and storage of the
vital dye neutral red in lysosomes. NF-κB activation was assessed
by the measurement of SEAP release in the supernatant of
HEK-Blue™ cells. Insulin secretion accumulated in the superna-
tant of RIN-m5F cells after 18 h was measured at the end of the
stimulation period by ELISA (EZRMI-13 K, EMD Millipore,
Billerica, USA). Insulin concentration was expressed as ng/mL per
106 living cells.
2.7. Immunological staining
Cells were fixed using Fix&Perm® kit (Caltag Laboratories,
Carlsbad, USA) and labeledwith 2.5 μg/mL TLR4-Phycoerythrin
(PE) monoclonal antibody (Abcam®, Cambridge, USA), or with
16 μg/mL MATG-1031 anti-CFTR monoclonal antibody (RD
Biotech, Besançon, France) and revealed by 2 μg/mL goat
anti-mouse PE secondary antibody (Beckman Coulter, Brea,
USA). Labeling was proven by flow cytometry using a FACS-
scan cytometer set at logarithmic gain and 10,000 events per
sample were recorded.
2.8. Evaluation of NF-κB activation and pathways targeted by
MPs
NF-κB activity was measured by SEAP Reporter Assay Kit
(InvivoGen) in HEK cells treated by 1 μg/mL LPS and 100 nM
MPs from CFPAC-1 or PANC-1 for 22 h. The concentration of
the yellow end-product was measured at 405 nm (VersaMax,
Molecular Devices). For detection of phosphorylated IκBα
(p-IκBα) in RIN-m5F, cells were incubated with IRAK or
TAK-1 inhibitors 30 min. before a 6 h-stimulation by MPs.
2.9. Western blot analysis
After treatment, cells were washed twice with PBS and then
lysed in TRIS buffer containing protease inhibitors (5 μg/mL
Leupeptin, 5 mM Benzamidine) and 2% Triton® X-100 on
ice. Total proteins (10 μg) were separated on 10% SDS-
polyacrylamide (Sigma) gels as previously described [13].
Membranes were incubated with the primary mouse antibody for
p-IκBα (US Biological, Swampscott, USA; 1:1000 dilution),
overnight at 4 °C. Detection of β-tubulin protein was used for
normalization and quantification. After washing, membranes
were incubated with the anti-mouse antibody (Cell SignalingTechnology, Danvers, USA) at 1:10,000 dilution at room
temperature for 60 min. Prestained markers (Invitrogen™,
Carlsbad, USA) were used for molecular mass determinations.
Immunoreactive bands were detected by enhanced chemilumi-
nescence (Amersham, GE Healthcare). Density analysis was
realized using ImageQuant LAS 4000 imager (GE Healthcare).
2.10. Statistics
All experiments were performed at least three times and
results expressed as means ± S.E.M. One-way ANOVA with
Tukey's post hoc tests and student's t test were performed for the
comparisons of groups using GraphPad Prism version 6.01 for
Windows™ (GraphPad Software, San Diego, USA). Statistical
significance was considered for p b 0.05.
3. Results
3.1. LPS effect on CFTR deficient cells
Firstly, we wanted to study the effect of LPS on apoptosis in
exocrine PANC-1, exocrine CFTR-deficient CFPAC-1, endo-
crine RIN-m5F and endocrine CFTR-inhibited RIN-m5F cells.
Our results showed that treatment with LPS significantly induced
apoptosis in both exocrine CFTR-deficient CFPAC-1 (Fig. 1A)
and endocrine CFTR-inhibited RIN-m5F cells (Fig. 1B). Con-
trary to PANC-1, LPS-challenged CFPAC-1 presented a 4-fold
increase in apoptosis. Furthermore, a decrease in lysosomal
activity from 100% to 82% was observed only in exocrine
mutated cells (data not shown). CFTR protein-receptor activity
inhibition in RIN-m5F using Inh-172 resulted in a 7-fold increase
of apoptosis, reaching 27.06 ± 2.6% (Fig. 1B). Addition of LPS
to those cells augmented apoptosis up to 41.5 ± 2.15%. LPS
alone did not induce apoptosis in normal RIN-m5F.
Because TLR4 and CFTR are two receptors for P. aeruginosa
LPS [7], their expression was studied in RIN-m5F cells. A shift of
red fluorescence intensity was observed after LPS challenge
indicating the enhanced expression of both receptors (Fig. 1C–D).
3.2. Contribution of MPs to endocrine dysfunction
Fluorescence microscopy evidenced that exocrineMPs adhere
and fuse with the target endocrine cell membrane (Fig. 2A–C).
Flow cytometry confirmed that approximately 82% of cells
presented specific fluorescence brought by MPs (Fig. 2D–F).
After 18 h, exocrine MPs isolated from both, mutated and
normal cells, induced apoptosis in target endocrine cells up to
7 ± 0.79% and 8.8 ± 1.15%, respectively (Fig. 3A). LPS alone
decreased lysosomal activity in endocrine RIN-m5F from 100%
to 82.3 ± 2%. This decrease was more pronounced when cells
were challenged by MPs from CFPAC-1. Conversely, MPs from
PANC-1 had no effect on the lysosomal activity (Fig. 3B). Under
conditions of LPS treatment and pharmacological inhibition
by Inh-172, MPs from exocrine mutated CFPAC-1 decreased the
lysosomal activity in RIN-m5F from 100% to 76.3 ± 4.5%
(Fig. 3C).
Fig. 1. Effect of CFTR deficiency in LPS-challenged exocrine and endocrine cells. CFPAC-1 and PANC-1 were incubated with 1 μg/mL LPS during 24 h (A), and
RIN-m5F during 18 h (B). Inh-172 (25 μM) was added to normal RIN-m5F (B). N = 5, ⁎⁎⁎p b 0.0001, ns: statistically not significant. Red fluorescent (FL2-H)
labeling of TLR4 and CFTR at membrane surface in LPS-stimulated RIN-m5F cells (C, D).
Fig. 2. Transfer of PKH26-labeled MPs from exocrine CFPAC-1 cells to endocrine target RIN-m5F cells. Cells were incubated with 10 nM MPs during 18 h and
analyzed by confocal microscopy (A–C). Flow cytometry evidenced a shift of red fluorescence (FL2-H) intensity brought by PKH26-labeled MPs in endocrine
RIN-m5F cells (D–F).
222 A.A. Constantinescu et al. / Journal of Cystic Fibrosis 13 (2014) 219–226
Fig. 3. Effect of exocrine MPs and LPS on the apoptosis (A) and lysosomal activity (B–C) of endocrine RIN-m5F cells. Cells were incubated with 10 nM MPs and
1 μg/mL LPS during 18 h. CFTR inhibition was achieved using 25 μM Inh-172 (C). MPs from CFPAC-1 exocrine cells (MPsCFPAC-1), MPs from PANC-1 exocrine
cells (MPsPANC-1), n = 5, ⁎p b 0.05, ⁎⁎p b 0.01, ⁎⁎⁎p b 0.0001, ns: statistically not significant.
Fig. 4. Effect of MPs from CFPAC-1 and CFTR-inhibited PANC-1 on the
insulin secreted by RIN-m5F. Insulin secretion was assessed after 18 h
treatment with 25 μM Inh-172 and 1 μg/mL LPS, n = 7 (A). Effect of 10 nM
MPs from CFPAC-1 on RIN-m5F, after 18 h treatment, n = 5 (B).
⁎⁎⁎p b 0.0001, ns: statistically not significant.
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As insulin secretion decrease is a specific marker for
endocrine dysfunction, we wanted then to evaluate the effect of
CFTR inhibition and exocrine MPs on insulin secretion level in
RIN-m5F cells. Treatment by 25 μM Inh-172 for 18 h induced
a sharp decrease in insulin secretion from 60.72 ± 1.57 ng/mL
to 22.39 ± 2.38 ng/mL per 106 cells (Fig. 4A). Addition of
LPS and LPS alone had no effect.
In contrast to PANC-1-derived MPs, MPs from CFPAC-1
decreased insulin secretion from 58 ± 1.27 ng/mL to 37.4 ±
0.96 ng/mL per 106 cells. Interestingly, MPs released from
Inh-172-treated PANC-1 cells decreased insulin secretion to a
similar extent induced by CFPAC-1-derived MPs (Fig. 4B).
3.4. MPs from CFPAC-1 cells activate NF-κB
After treatment by 100 nM CFPAC-1-derived MPs, SEAP
concentration in the supernatant of HEK-Null2 reporter cells
increased by approximately 163%, while additional LPS remained
ineffective, indicating that MPs delivered saturated amounts of
TLR4-LPS complex to target cells. In contrast, PANC-1-derived
MPs did not stimulate SEAP secretion, confirming the specificity
of CFTR deficiency in MP-mediated cell response (Figs. 5A and
6). TLR4 delivery by MPs was also observed in HEK-hTLR4
control cells, where NF-κB activity could be enhanced by LPS
challenge most probably through its binding to free initial cell
receptors (Fig. 6).
Treating RIN-m5F cells by CFPAC-1-derived MPs signif-
icantly decreased insulin secretion from 13.9 ± 0.6 ng/mL to
10.8 ± 0.6 ng/mL per 3 × 105 cells (Fig. 5B). Interestingly, an
inhibitor of either IRAK-1/4 or TAK-1 was able to abrogate the
effect of MPs (Fig. 5B).
A strong MP-mediated NF-κB activation was further demon-
strated by highly phosphorylated IκB, an indicator of NF-κBactivation. Their effect was inhibited by IRAKi and TAK-1i
(Fig. 5C).
4. Discussion
Our MP-mediated cross-talk model was based on the
previous clinical observations of an increased risk of diabetes
under the conditions of recurrent endotoxemia and low-grade
inflammation [14,15]. LPS from P. aeruginosa was chosen as
an inducer of pancreatic cell stress because it is more relevant to
the clinical infection background in CF. However, since only
exocrine pancreatic cell lineage is available and no human
Fig. 5. NF-κB activation in HEK-Null2 reporter cells and RIN-m5F. Null2
engineered HEK cells that are devoid of TLR4 and cannot initiate TLR4-
mediated NF-κB activation, were submitted to 100 nM MPs from exocrine
CFPAC-1 and PANC-1, and challenged by LPS. NF-κB activation was
revealed by SEAP Reporter Gene System after 22 h of incubation, n = 6,
⁎⁎⁎p b 0.0001 (A). Insulin secretion was measured in the supernatant of
RIN-m5F treated by 10 nM MPs from CFPAC-1 during 6 h and pretreated by
IRAK or TAK-1 MAP kinase inhibitors during 30 min., n = 5, ⁎⁎p b 0.01,
⁎⁎⁎p b 0.0001, ns: statistically not significant (B). IκB phosphorylation in
RIN-m5F treated by MPs from CFPAC-1 and inhibitors as in B (C). One
representative immunoblot of three different performed showing control cells
(1), MP-treated (2), IRAKi-pretreated followed by MP treatment (3), and
TAK-1i-pretreated followed by MP treatment (4). Results were reproducible for
three distinct manipulations.
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Fig. 6. NF-κB activation in HEK-hTLR4 reporter cells challenged by LPS.
hTLR4 engineered HEK cells express human TLR4 and are able to initiate
TLR4-mediated NF-κB activation. They were submitted to 100 nM MPs from
exocrine CFPAC-1 and PANC-1, and challenged by LPS. NF-κB activation
was revealed by SEAP Reporter Gene System after 22 h of incubation, n = 6,
⁎⁎⁎p b 0.0001.
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insulin-secreting β-cells were used as MP targets [17]. CFTR
activity at endocrine cell surface was further inhibited using the
potent rapid-acting Inh-172 that binds to CFTR channel, to
mimic CFTR dysfunction.
4.1. CFTR, cell response to LPS and insulin secretion
Our findings are indicative of cell specific consequences of
CFTR deficiency, especially in the initiation of apoptosis [8].To the best of our knowledge, this is the first report of LPS
effects on pancreatic ductal cell lines bearing CFTRΔF508
mutation [18]. Ductal cells are key components of the exocrine
pancreas and contribute to CF-induced inflammation [19,20].
Our data demonstrate that, contrary to their normal counter-
parts, exocrine CFTRΔF508-mutated cells are highly sensitive
to apoptotic stress in response to P. aeruginosa LPS. They
presented a decreased metabolic activity, along with enhanced
TLR4 expression. Moreover, in LPS-treated endocrine cells, an
increased CFTR expression suggests its contribution to NF-κB
mediated cell response. Indeed, CFTR was reported as a specific
receptor for P. aeruginosa endotoxin [21,22].
Although, deleterious effects of all-origin LPS have been
reported in endocrine pancreas [23,24], we could not evidence
LPS-induced apoptosis in our endocrine cell model. Nevertheless,
LPS-challenged endocrine cells showed an important decrease in
viability, detected by reduced lysosomal activity, in accordance
with previous data [23,24]. LPS from P. aeruginosa alone did not
induce the decrease of insulin secretion in our model, contrary to
previous reports in human primaryβ-cells, murineMIN-6 cell line,
or even mouse and rat islets [23,25]. This apparent discrepancy
could be due to differences in cell lineages, LPS type or time
duration of stimulation, although, the lack of LPS effect on insulin
secretion has also been mentioned in acute stimulation, showing
the importance of the experimental model [26]. However, we could
evidence a direct link between CFTR inhibition and insulin
secretion. CFTR inhibition led to decreased insulin secretion along
with exaggerated apoptosis that was even enhanced by LPS. These
data are strongly suggestive of an insulin deficiency occurring in
CF as a result of CFTR dysfunction in β-cells, independently of
duct obstruction. Further molecular exploration of CFTR-related
insulin secretion impairment is needed for a better understanding of
the underlying mechanism.
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secretion
MPs represent a fairly recent field of research and there is a
growing literature describing their properties as biomarkers of
cell damage or dysfunction in many physiological settings such
as coagulation or inflammation [9]. MPs can act as bioactive
effectors, modulating intercellular signaling [10,27]. MPs of
vascular origin have been extensively studied but data concerning
MPs from pancreas are lacking.We could evidence the generation
ofMPs from exocrine CFTRΔF508-mutated cells and probe their
interaction with endocrine cells, leading to major apoptotic effect
correlated with the decrease in lysosomal activity. In contrast,
exocrine control MPs not only remained ineffective on RIN-m5F
lysosomal activity but also protected target cells against LPS
action, showing the importance of CFTR protein in the cell
metabolism. The most surprising action of exocrine MPs was
the strong decrease in insulin secretion prompted by those
from CFPAC-1 or from normal cells treated by CFTR Inh-172.
Interestingly, endocrine cells treated by CFPAC-1-derived
MPs showed apoptosis and insulin impairment, while control
MP-treated cells showed an almost similar degree of apoptosis
without modification of insulin secretion. Altogether, data
indicate that apoptosis was not directly involved in insulin
impairment. Furthermore, CFTR protein activity at cell mem-
brane appears pivotal in the delivery of MP signals.
Although it is tempting to draw a similar picture of MPs and
cell deficiency in CFTR, our cross-talk model rather supports the
idea that MPs deliver a low amount of deleterious molecules that
is enhanced when CFTR mutation is present. Conversely, CFTR
expressed at cell and MP membranes could be protective and its
absence reveals a defective counter balance of deleterious
messages borne by MPs. Data from Inh-172-challenged cell-
derived MPs fit with this hypothesis (Fig. 4B).
4.3. Inhibition of NF-κB restores insulin secretion
The influence of inflammation on insulin secretion via NF-κB
activation remains a matter of debate [25]. The ability of exocrine
MPs alone to target and strongly activate NF-κB raised the
question of a possible delivery of LPS through TLR4-CD14-LPS
complex. Challenge by LPS was ineffective, probably due to the
saturation of TLR4 receptors delivered by MPs. Surprisingly,
MPs from PANC-1 were not able to mobilize NF-κB, in
accordance with the hypothesis of CFTR-related cytoprotective
effect [28,29].
Although we could verify that TLR4 as well as CFTR are
expressed by RIN-m5F cells (Fig. 1C,D), free LPS had no
effect neither on insulin secretion nor on apoptosis of ß-cells.
Our data question the role of free LPS in the complex
environment of the islet and suggest that exocrineMPs are able to
capture and concentrate an active form of LPS at the vicinity of
endocrine cells. Mechanisms of an MP-driven TLR4-targeted
NF-κB pathway and of its tuning in the restoration of insulin
secretion remain elusive. Together with TLR4 and co-adaptor
MD2 membrane delivery, MP could also bring a more favorable
hindrance to the LPS-TLR4 complex or have transfer kinases andfarnesylated proteins already recruited at plasmamembrane in their
active form. IRAK and TAK kinases are two TLR4 downstream
actors in the LPS-induced NF-κB activation cascade. In our hands,
their inhibition succeeded to restore insulin secretion in RIN-m5F
cells challenged by exocrine CFPAC-1-derived MPs. Moreover,
low levels of phosphorylated IκB, the activated form of the IκB
protein responsible for keeping NF-κB inactive, were linked to
normal insulin secretion. Altogether, these data emphasize the
tight connection between insulin secretion and NF-κB in the MP
cross-talk between exocrine and endocrine pancreas.
In conclusion, our data are in favor of a specific role of CFTR
in the pancreatic cell homeostasis directly linked to NF-κB.
Indeed, exocrine cells with CFTRΔF508 mutation or endocrine
CFTR-inhibited cells present an exaggerated susceptibility to LPS
from P. aeruginosa. Enhanced exocrine apoptosis and consecu-
tive MP shedding appear as keys to the delivery of a deleterious
message from mutated cells to target endocrine ones. Our data
point at MP-mediated pancreatic function degenerescence in CF.
Hence, in the context of CF recurrent infections, MPs released
from LPS-damaged exocrine cells could be viewed as direct
effectors of endocrine pancreatic progressive dysfunction.
Funding
This research was supported by the Sectorial Operational
Programme Development of Human Resources 2007–2013
(POSDRU) through the Financial Agreement POSDRU/107/
1.5/S/76888 of the Government of Romania, recurrent funding,
by the Association Vaincre la Mucoviscidose (VLM) and by
the Aide à Domicile aux Insuffisants Respiratoires d'Alsace
Lorraine (ADIRAL).
References
[1] Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Hoiby N, et al.
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an
evolutionary perspective. Nat Rev Microbiol 2012;10(12):841–51.
[2] Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst
Fibros 2013. http://dx.doi.org/10.1016/j.jcf.2013.02.008.
[3] Valour F, Brault C, Abbas-Chorfa F, Martin C, Kessler L, Kanaan R, et al.
Outcome of cystic fibrosis-related diabetes two years after lung transplan-
tation. Respiration 2012. http://dx.doi.org/10.1159/000339928.
[4] Bridges N. Diabetes in cystic fibrosis. Paediatr Respir Rev 2013. http://
dx.doi.org/10.1016/j.prrv.2013.02.002.
[5] Hoelen H, Kleizen B, Schmidt A, Richardson J, Charitou P, Thomas PJ,
et al. The primary folding defect and rescue of deltaf508 CFTR emerge
during translation of the mutant domain. PLoS One 2010;5(11):e15458.
[6] Bertrand CA, Frizzell RA. The role of regulated CFTR trafficking in
epithelial secretion. Am J Physiol Cell Physiol 2003;285(1):C1–C18.
[7] Kowalski MP, Pier GB. Localization of cystic fibrosis transmembrane
conductance regulator to lipid rafts of epithelial cells is required for
Pseudomonas aeruginosa-induced cellular activation. J Immunol
2004;172(1):418–25.
[8] Rottner M, Kunzelmann C, Mergey M, Freyssinet J-M, Martínez MC.
Exaggerated apoptosis and NF-κB activation in pancreatic and tracheal
cystic fibrosis cells. FASEB J 2007;21(11):2939–48.
[9] Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz
RM. Microparticles: biomarkers and beyond. Clin Sci 2013;124(7):423–41.
[10] Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a
disseminated storage pool of bioactive vascular effectors. Curr Opin
Hematol 2004;11(3):156–64.
226 A.A. Constantinescu et al. / Journal of Cystic Fibrosis 13 (2014) 219–226[11] Porro C, Di Gioia S, Trotta T, Lepore S, PanaroMA, Battaglino A, et al. Pro-
inflammatory effect of cystic fibrosis sputum microparticles in the murine
lung. J Cyst Fibros 2013. http://dx.doi.org/10.1016/j.jcf.2013.03.002.
[12] Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biro E, Nieuwland R, et al.
Measuring circulating cell-derived microparticles. J Thromb Haemost
2004;2(10):1842–51.
[13] Alhosin M, Ibrahim A, Boukhari A, Sharif T, Gies JP, Auger C,
et al. Anti-neoplastic agent thymoquinone induces degradation of
alpha and beta tubulin proteins in human cancer cells without
affecting their level in normal human fibroblasts. Invest New Drugs
2012;30(5):1813–9.
[14] Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V.
Endotoxemia is associated with an increased risk of incident diabetes.
Diabetes Care 2011;34(2):392–7.
[15] Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A,
Fernandez-Real JM, et al. Increase in plasma endotoxin concentrations and
the expression of toll-like receptors and suppressor of cytokine signaling-3 in
mononuclear cells after a high-fat, high-carbohydrate meal implications for
insulin resistance. Diabetes Care 2009;32(12):2281–7.
[16] Ravassard P, Hazhouz Y, Pechberty S, Bricout-Neveu E, Armanet M,
Czernichow P, et al. A genetically engineered human pancreatic β cell
line exhibiting glucose-inducible insulin secretion. J Clin Invest
2011;121(9):3589–97.
[17] Kopeikin Z, Sohma Y, Li M, Hwang T-C. On the mechanism of CFTR
inhibition by a thiazolidinone derivative. J Gen Physiol 2010;136(6):659–71.
[18] Fortunato F, Deng X, Gates LK, McClain CJ, Bimmler D, Graf R, et al.
Pancreatic response to endotoxin after chronic alcohol exposure: switch
from apoptosis to necrosis? Am J Physiol Gastrointest Liver Physiol
2006;290(2):G232–41.
[19] Naruse S, Kitagawa M, Ishiguro H, Fujiki K, Hayakawa T. Cystic fibrosis
and related diseases of the pancreas. Best Pract Res Clin Gastroenterol
2002;16(3):511–26.[20] Stecenko AA, Moran A. Update on cystic fibrosis-related diabetes. Curr
Opin Pulm Med 2010;16(6):611–5.
[21] Schroeder TH, LeeMM, Yacono PW, CannonCL, Gerçeker AA, Golan DE,
et al. CFTR is a pattern recognition molecule that extracts Pseudomonas
aeruginosa LPS from the outer membrane into epithelial cells and
activates NF-kappa B translocation. Proc Natl Acad Sci U S A
2002;99(10):6907–12.
[22] Goldberg JB, Pier GB. The role of the CFTR in susceptibility to
Pseudomonas aeruginosa infections in cystic fibrosis. Trends Microbiol
2000;8(11):514–20.
[23] Garay-Malpartida HM, Mourão RF, Mantovani M, Ia Santos, Sogayar
MC, Goldberg AC. Toll-like receptor 4 (TLR4) expression in human and
murine pancreatic beta-cells affects cell viability and insulin homeostasis.
BMC Immunol 2011;12(1):18.
[24] Ge QM, Du SC, Bian F, Lin N, Su Q. Effects of lipopolysaccharides
on TLR4 expression in Ins-1 rat insulinoma cells. Cell Mol Biol
2011;57(Suppl.):OL1513–9.
[25] Amyot J, Semache M, Ferdaoussi M, Fontés G, Poitout V. Lipopolysac-
charides impair insulin gene expression in isolated islets of langerhans via
toll-like receptor-4 and NF-κB signalling. PLoS One 2012;7(4):e36200-e.
[26] Liu S-Y, Liang Q-J, Lin T-X, Fan X-L, Liang Y, Heemann U, et al.
Lipopolysaccharide-enhanced early proliferation of insulin secreting Nit-1
cell is associated with Nuclear Factor-KappaB-mediated inhibition of
caspase 3 cleavage. Chin Med J (Peking) 2011;124(22):3652–6.
[27] Reid VL, Webster NR. Role of microparticles in sepsis. Br J Anaesth
2012;109(4):503–13.
[28] Vij N, Mazur S, Zeitlin PL. CFTR is a negative regulator of NF-κB
mediated innate immune response. PLoS One 2009;4(2):e4664.
[29] Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C, et al. Loss
of CFTR affects biliary epithelium innate immunity and causes TLR4-
NF-κB-mediated inflammatory response in mice. Gastroenterology
2011;141(4):1498–508 [508.e1-5].
